Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ether doai
Patent
1997-01-27
1999-11-23
Rotman, Alan L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ether doai
568683, 568684, A61K 3108, C07C 4312
Patent
active
059901764
ABSTRACT:
The present invention relates to an anesthetic composition containing a fluoroether compound and a physiologically acceptable Lewis acid inhibitor. This composition exhibits improved stability and does not readily degrade in the presence of a Lewis acid.
REFERENCES:
patent: 2992276 (1961-07-01), Weinmayr
patent: 3527813 (1970-09-01), Terrell
patent: 3689571 (1972-09-01), Regan et al.
patent: 4080389 (1978-03-01), Moilliet
patent: 4250334 (1981-02-01), Coon et al.
patent: 4469898 (1984-09-01), Coon et al.
Sevoflurane Water Content, Abbott Laboratories.
XP-002061443; "The Degradation, Absorption, and Solubility of Volatile Anesthetics in Soda Lime Depend on Water Content"; David P. Strum, MD, FRCP, and Edmond I. Eger II, MD; vol. 78. No. 2; Feb. 1994; Baltimore; pp. 340-348.
XP00206144; Dressing J., Sprenger A., Kieviet O.S.: "Repertorium 94/95", 1994, NL., S-Gravenhage, SDU, The Hague.
USP XXII, Official Monographs, p. 726 (isoflurane).
A. Carre, F. Roger, and C. Varinot, "Study ofAcid/Base Properties of Oxide, Oxide Glass and Glass-Ceramic Surfaces," Journal of Colloid and Interface Science, vol. 154, No. 1, Nov. 1972.
M. Hair, "The Nature of Leached Glass Surfaces," Clean Surfaces: Their Preparation and Characterization for Interfacial Studies, Published by Marcel Dekker, Inc., (New York) 1970.
I. Chistovskaya and F. Janowski, "Acidic and Catalytic Properties of Boron-Containing Porous Glasses," React. Kinet. Catal. Lett., vol. 43, No. 2, 277-282 (1991).
J. Jednacak-Biscan, V. Pravdic, and W. Haller, Adsorption Phenomena on Glass Surfaces, Journal of Colloid and Interface Science, vol. 121, No. 2, Feb. 1988.
J. March, "Advanced Organic Chemistry," McGraw-Hill Book Company (New York).
Smith, I. et al.: Comparison of Induction, Maintenance, and Recovery Characteristics of Sevoflurane-N.sub.2 O and Propofol-Sevoflurane-N.sub.2 O with Propofol-Isoflurane-N.sub.2 O Anesthesia. Anesth. Analg. vol. 74, pp. 253-259, 1992.
Bieniarz Christopher
Chang Steve H.
Cromack Keith R.
Huang Shuyen L.
Kawai Toshikazu
Abbott Laboratories
Aulakh Charanjit S.
Central Glass Company Ltd.
Rotman Alan L.
Woodworth Brian R.
LandOfFree
Fluoroether compositions and methods for inhibiting their degrad does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fluoroether compositions and methods for inhibiting their degrad, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fluoroether compositions and methods for inhibiting their degrad will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1222632